Pharmaceutical Industry

Senate Finance Committee Chairman Orrin Hatch, R-Utah, announced on Tuesday that Alex Azar (pictured above), President Trump's nominee to become Secretary of Health and Human Services, will be part of a hearing next week.

Healthcare

HHS to expand negotiating power for Medicare

August 7, 2018 8:59 pm

OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt.

Business

House lawmakers probe opioid makers’ role in epidemic

Robert King -

August 3, 2018 3:10 pm

Sen. Claire McCaskill, D-Mo., speaks at the dedication for Gateway Arch National Park Tuesday, July 3, 2018, in St. Louis. The $380 million renovation to the park surrounding the Gateway Arch is the first major renovation since the monument opened in 1965 and one Missouri political leaders see as a template for the future of the national park system.

Healthcare

Letting Medicare negotiate drug prices could save nearly $3 billion: Democratic report

Robert King -

August 1, 2018 3:03 pm

Business

Despite price hikes, older drugs weigh on Pfizer’s profits

Joe Williams -

July 31, 2018 9:43 am

Healthcare

Midterm election candidates attacked over high drug prices

Robert King -

July 31, 2018 12:00 am

The failures of UK's National Health Service serves as a warning for what the Affordable Care Act will do to health care in the U.S. (Photo: Thinkstock)

Beltway Confidential

The real reason to be skeptical of single-payer healthcare is not cost but government mismanagement

Erin Dunne -

July 30, 2018 10:25 pm

A sign reads "Consultation" at the pharmacy window inside a Walgreens Boots Alliance Inc. store in the Hollywood neighborhood of Los Angeles, California, on Oct. 19, 2017.

Healthcare

House lawmakers want federal probe of drug middlemen mergers

Robert King -

July 27, 2018 7:29 pm

Healthcare

Lawmakers aim to stop use of pill machines used to boost opioid epidemic

Robert King -

July 26, 2018 9:03 pm

Healthcare

Trump administration calls for more cuts to drug discount program for safety net hospitals

Robert King -

July 25, 2018 10:18 pm

$FILE - In this file photo taken Thursday, Feb. 9, 2012, a pharmacist is seen working in a lab where medicines are being produced at a manufacturing unit on the outskirts of Mumbai, India. India's patent office on Monday march 12, 2012 effectively ended Bayer's monopoly on a patented cancer drug by allowing the manufacturing of a generic copy at a fraction of the price.$

Healthcare

Eli Lilly opposes using imports to tackle high drug prices

Robert King -

July 24, 2018 2:27 pm

1...808182...160 Page 81 of 160

Tag: Pharmaceutical Industry

HHS to expand negotiating power for Medicare

House lawmakers probe opioid makers’ role in epidemic

Letting Medicare negotiate drug prices could save nearly $3 billion: Democratic report

Despite price hikes, older drugs weigh on Pfizer’s profits

Midterm election candidates attacked over high drug prices

The real reason to be skeptical of single-payer healthcare is not cost but government mismanagement

House lawmakers want federal probe of drug middlemen mergers

Lawmakers aim to stop use of pill machines used to boost opioid epidemic

Trump administration calls for more cuts to drug discount program for safety net hospitals

Eli Lilly opposes using imports to tackle high drug prices

NEWS

POLICY

COMMENTARY

RESTORING AMERICA